Performance of existing risk scores around heart transplantation: validation study in a 4-year cohort.
Lee S NguyenGuillaume CoutanceSalima OuldamarNoel ZahrNicolas BrechotAntonella GaleoneAdrien BougleGuillaume LebretonPascal LeprinceShaida VarnousPublished in: Transplant international : official journal of the European Society for Organ Transplantation (2018)
Several risk scores exist to help identify best candidate recipients for heart transplantation (HTx). This study describes the performance of five heart failure risk scores and two post-HTx mortality risk scores in a French single-centre cohort. All patients listed for HTx through a 4-year period were included. Waiting-list risk scores [Heart Failure Survival Score (HFSS), Seattle Heart Failure Model (SHFM), Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC), Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) and Get With The Guidelines-Heart Failure (GWTG-HF)] and post-HTx scores Index for Mortality Prediction After Cardiac Transplantation (IMPACT and CARRS) were computed. Main outcomes were 1-year mortality on waiting list and after HTx. Performance was assessed using receiver operator characteristic (ROC), calibration and goodness-of-fit analyses. The cohort included 414 patients. Waiting-list mortality was 14.0%, and post-HTx mortality was 16.3% at 1-year follow-up. Heart failure risk scores had adequate discrimination regarding waiting-list mortality (ROC AUC for HFSS = 0.68, SHFM = 0.74, OPTIMIZE-HF = 0.72, MAGGIC = 0.70 and GWTG = 0.77; all P-values <0.05). On the contrary, post-HTx risk scores did not discriminate post-HTx mortality (AUC for IMPACT = 0.58, and CARRS = 0.48, both P-values >0.50). Subgroup analysis on patients undergoing HTx after ventricular assistance device (VAD) implantation (i.e. bridge-to-transplantation) (n = 36) showed an IMPACT AUC = 0.72 (P < 0.001). In this single-centre cohort, existing heart failure risk scores were adequate to predict waiting-list mortality. Post-HTx mortality risk scores were not, except in the VAD subgroup.
Keyphrases
- heart failure
- cardiovascular events
- left ventricular
- end stage renal disease
- acute heart failure
- systematic review
- patients undergoing
- risk factors
- ejection fraction
- cardiovascular disease
- chronic kidney disease
- newly diagnosed
- type diabetes
- randomized controlled trial
- peritoneal dialysis
- clinical trial
- magnetic resonance imaging
- adipose tissue
- coronary artery disease
- bone marrow
- prognostic factors
- skeletal muscle
- insulin resistance
- open label
- mesenchymal stem cells
- weight loss
- catheter ablation